• M A Kemler, G A Barendse, M Van Kleef, F A Van Den Wildenberg, and W E Weber.
• Department of Surgery (Pain Management and Research Centre), Maastricht University Hospital, The Netherlands. mkeml@shee.azm.nl
• J. Neurosurg. 1999 Jan 1;90(1 Suppl):79-83.

ObjectThe aim of the study was to assess retrospectively the clinical efficacy and possible adverse effects of electrical spinal cord stimulation (SCS) for the treatment of patients with reflex sympathetic dystrophy (RSD).MethodsTwenty-three patients who suffered severe pain due to RSD were included in the study. The SCS system was implanted only after a positive 1-week test period. The visual analog scale (VAS) score for pain (1-10) was obtained in all patients prior to treatment, 1 month postimplantation, and at last follow up. At final follow-up examination, patients were asked to rate the effect of their treatment on the 7-point global perceived effect scale. Eighteen (78%) of 23 patients treated between 1991 and 1997 reported improvement during the test period. Permanent implantation of SCS system was not performed in the other five patients. Complications occurred in nine (50%) of 18 patients. The system was removed in three patients after implantation (17%). At the end of follow up (mean 32 months) 15 patients still had an implanted system. The mean pain score had decreased from 7.9 to 5.4 (p<0.001). In the other eight patients the pain score had not changed significantly. In 13 patients (57%) in whom the SCS system was implanted, clinical status had much improved or improved; these cases were regarded as successful.ConclusionsIn this retrospective series, the majority of patients with RSD reported a subjective improvement after implantation of an SCS system.

11 keywords...

hide…